ChartMill assigns a fundamental rating of 3 / 10 to PRNB.
ChartMill assigns a valuation rating of 1 / 10 to Principia Biopharma Inc (PRNB). This can be considered as Overvalued.
Principia Biopharma Inc (PRNB) has a profitability rating of 2 / 10.
The Earnings per Share (EPS) of Principia Biopharma Inc (PRNB) is expected to decline by -33.49% in the next year.